Ledger.Open graph →
SEC Form D · filed December 16, 2020

Auron Therapeutics, Inc

Offering
$15.4M
Sold
$15.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WELLESLEY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

John D. Higgons · Wellesley, MADirectorIsaac Ciechanover · Wellesley, MADirectorMark Dinner · Dover, DEDirectorHanxiong Li · Laguna Hills, CADirectorSteven Glick · Brooklyn, NYDirectorAlon D. Lazarus · Wellesley, MADirectorWilliam Hapworth · Brooklyn, NYDirectorMatthew Glick · Brooklyn, NYDirectorRonald D. Dodson · Dallas, TXExec · DirectorRicardo Bekin · Chicago, ILExec · DirectorJames Mackay · Laguna Hills, CADirectorIsaac Ciechanover · Wellesley, MADirectorKatharine Yen · Wellesley, MAExec · DirectorAnna D. French · Wellesley, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗